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INTRODUCTION & OBJECTIVES: To compare perioperative outcomes of open partial nephrectomy (OPN) with those of robotic assisted partial 
nephrectomy (RAPN), in a prospective multicenter dataset.
MATERIAL & METHODS: The AGILE project is a 2-Year prospective observational study that includes patients treated with OPN or RAPN between  2010 
and 2011 at six Italian urologic centers. All clinical variables including tumor nephrometry (PADUA score) and laboratory analyses were recorded. Surgical 
results and complications, stratified with Clavien system, and pathological data were registered. All significant differences  in OPN versus RAPN group were 
assessed. Independent predictors of surgical complications were evaluated with multivariate analysis.
RESULTS: 198 and 104 patients were enrolled in the OPN and RAPN group, respectively.  As summarized in the table, Charlson comorbility index was 
significantly higher in RAPN group while clinical tumor diameter and imperative surgical indication were higher in OPN group.
Pedicle clamping was used in 48% and 62,5% of OPN and RAPN group, respectively. In RAPN group 1 procedure was converted to open due to vascular 
lesion. At univariate analysis, there was no significant difference in warm ischemia time, intraoperative complications, postoperative medical complications, 
delta of serum creatinine, positive surgical margin and benign tumor rates. The operative time resulted significantly higher in RAPN group, while the 
estimated blood loss, the delta of serum Hemoglobin and the postoperative surgical complications were significantly higher in OPN group. 9,6% of Clavien 
grade 3-4 surgical complications occurred in OPN group, while 1 in RAPN group (p=0,001). Ureteral stenting for urinary fistula was needed in 4% and 0% in 
the OPN and RAPN group, respectively (p=0,008). Revision of postoperative bleeding was needed in 2,5% and 1% (p=0,07). At multivariate analysis, the 
imperative indication and the surgical approach (Open vs Robotic) resulted independently correlated with postoperative surgical complications (RR=3,8; 
p=0,05 and RR=4,2; p=0,01,respectively).
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Partial nephrectomy OPN RAPN P
N patients 198 104 Ns
Male gender 62% 65.4% Ns
Age   (years) 63,8  ± 12,4 63 ± 11 Ns
BMI 27,2 ± 4,9 26,1 ± 4 Ns
ASA score 3 14,6% 14% Ns
Charlson Index ≥ 2 5,6% 26% 0,04
Imperative indications 5,05% 1% 0,07
CONCLUSIONS: In our analysis the robotic approach clearly improved the incidence of postoperative complication and the reintervention rate. Further 
studies are needed to evaluate surgical, functional and oncological results of RAPN.
Clinical tumor diameter 3,5 ± 1,8 2,8 ± 1,5   cm 0,0002
PADUA score ≥ 10 7,1% 6.3% Ns
Reduction of Hb  (g/dL) 3,1 ± 1,9 2,3  ± 1,5 0,0019
Increase of serum creatinine (mg/dL) 0,2 ± 0,3 0,3 ± 0,1 Ns
WIT (min) 18,7  ± 8,1 18,2 ± 7 Ns
Operative time (min) 123  ± 43 168 ± 56 <0,0001
EBL (mL) 230 ± 208 115 ± 107 0,0004
Intraoperative complications (%) 5,1% 2.9% Ns
Conversion to open - 1/104      1% Ns
Overall postoperative complications 48/198       24,2% 9/104     8,7% Ns
SURGICAL postoperative complications 42/198   21,2% 6/104     5,8% <0,0001
MEDICAL postoperative complications 3,0% 2,9% Ns
Clavien 3-4 surgical complications 19/198          9,6% 0 0,001
Urinary fistula with ureteral stent 8/198          4,0% 0 Ns
Clavien 3-4 postoperative bleeding 5/198         2,5% 1/104   1% 0,07
Benign tumors 21,2% 13,5% Ns
pT3a (invasion of perirenal fat) 6,0% 9,6% Ns
Positive surgical margins 5,8% 5,3% Ns
